Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Peripheral Arterial Disease Market Over the 2025–2034 Period?

In the past few years, the market size of peripheral arterial disease has seen considerable growth. It is predicted to expand from $4.36 billion in 2024 to $4.76 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%. The significant expansion in the aforementioned period can be tied to the advent of innovative medical devices, the improvement in gene therapy and regenerative medicine, advancements in pharmacogenomics, and the rise of digital health and remote monitoring services.

The market for peripheral arterial disease is set to experience robust expansion in the coming years, with a projected size of $6.62 billion by 2029, fuelled by a compound annual growth rate (CAGR) of 8.6%. The predicted upswing during the forecast period is linked to factors such as interdisciplinary care teams, lesser invasive procedures, and lifestyle and exercise prescriptions. Noteworthy trends during the forecast timeline encompass vascular tele-rehabilitation, multifaceted pain management, advancements in wound care, as well as public health initiatives.

Which Primary Drivers Are Supporting the Continued Expansion of the Peripheral Arterial Disease Market?

The continuous surge in cardiac diseases is fuelling the expansion of the peripheral arterial disease market. As an ordinary heart disease that affects the chief blood vessels providing blood to the heart muscle, cardiac disease necessitates the assistance of peripheral arterial disease treatment. This treatment offers heart patients advantages such as ameliorated blood flow, mitigation of cardiovascular risk, symptom respite, and an uplifted quality of life. For example, in December 2023, the Australian Bureau of Statistics (ABS), an Australia-based government department, reported that back in 2022, exactly one in twenty individuals (translating to 5.2% or roughly 1.3 million people) were suffering from heart conditions, strokes, and vascular diseases. Furthermore, the American College of Cardiology, a non-profit medical association from the US reported in April 2022 that the danger factors for ischemic heart disease are predicted to ascend by 30.7% to 29 million by 2025. As such, the escalating incidence of cardiac diseases is spurring the growth of the peripheral arterial disease market. Shifting focus to another driver, the mounting proliferation of diabetes anticipates expanding the peripheral arterial diseases market. Diabetes is an enduring, metabolic disorder that results in amplified levels of blood glucose or blood sugar. The growing prevalence of diabetes amplifies the need for treatments for this disorder. The exacerbated incidence of diabetes contributes to peripheral arterial disease (PAD), with individuals diagnosed with diabetes facing an increased likelihood of developing atherosclerosis, the leading cause of PAD that calls for treatment. For example, The Office for Health Improvement and Disparities (OHID), a government agency from the UK, reported in March 2024 that the percentage of individuals suffering from type 1 diabetes who received eight care processes witnessed a 22% increase from the 15 months that ended in March 2022 to those ending in March 2023. For type 2 diabetes, the upsurge was 21%. Consequently, the escalating rate of diabetes is propelling the expansion of the peripheral arterial disease market.

Explore Comprehensive Insights Into The Global Peripheral Arterial Disease Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Peripheral Arterial Disease Market?

Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

What Impact Are Industry Trends Having on the Peripheral Arterial Disease Market’s Future Prospects?

Major market players in the peripheral arterial disease sector are concentrating on the production of innovative health equipment, like the intravascular lithotripsy (IVL) catheter, to augment the effectiveness of treatments, improve the health outcomes for patients, and lessen recovery periods for those afflicted by vascular diseases. The intravascular lithotripsy (IVL) catheter, a type of medical tool, is used in the treatment of calcified blockages in arteries by applying controlled shockwaves that fragment the calcium, thus enhancing blood circulation and vessel suppleness during procedures like angioplasty. For example, Shockwave Medical, Inc., a medical tech firm based in the U.S., introduced the Shockwave E8 peripheral IVL catheter in September 2024. This medical tool, intended for the treatment of peripheral arterial disease, delivers targeted intravascular lithotripsy that uses sound waves to fragment calcium accumulation in the walls of arteries. This inventive technique aids in restoring blood circulation while keeping trauma to peripheral tissues to a minimum. The superior design of the catheter enables easier maneuvering through complicated vascular structures, making it ideal for a broad spectrum of patients.

Secure Your Global Peripheral Arterial Disease Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Which Primary Segments of the Peripheral Arterial Disease Market Are Driving Growth and Industry Transformations?

The peripheral arterial disease market covered in this report is segmented –

1) By Treatment Type: Devices, Catheters, Drugs, Other Types

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations

3) By End User: Hospitals, Specialty Clinics, Others End-Users

Subsegments:

1) By Devices: Stents, Balloons, Atherectomy Devices

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

What Regions Are Leading the Growth Trajectory of the Peripheral Arterial Disease Market?

North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Do Experts Define the Scope of the Peripheral Arterial Disease Market?

Peripheral arterial disease (PAD) refers to a medical condition characterized by the narrowing or blockage of the arteries that supply blood to the extremities, typically the legs and feet. It is a type of atherosclerosis, which is an accumulation of fat cells (plaque) in the arteries, leading to reduced blood flow. The treatment of the disease involves a combination of lifestyle modifications, medications and medical procedures aimed at increasing blood supply to the affected extremities, providing symptom relief and lowering the risk of consequences.

Browse Through More Similar Reports By The Business Research Company:

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Collection Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: